Retrospective Study
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Sep 27, 2024; 16(9): 2910-2924
Published online Sep 27, 2024. doi: 10.4240/wjgs.v16.i9.2910
Preoperative systemic inflammatory response index as a prognostic marker for distal cholangiocarcinoma after pancreatoduodenectomy
Wen-Hui Zhang, Yu Zhao, Cheng-Run Zhang, Jin-Can Huang, Shao-Cheng Lyu, Ren Lang
Wen-Hui Zhang, Cheng-Run Zhang, Jin-Can Huang, Shao-Cheng Lyu, Ren Lang, Department of Hepatobiliary Surgery, Beijing Chao-Yang Hospital Affiliated to Capital Medical University, Beijing 100020, China
Yu Zhao, Department of Urology Surgery, Beijing Chao-Yang Hospital Affiliated to Capital Medical University, Beijing 100020, China
Co-corresponding authors: Shao-Cheng Lyu and Ren Lang.
Author contributions: Zhang WH and Zhao Y collected the related papers and drafted the manuscript; Zhang WH, Zhao Y, Zhang CR and Huang JC collected data; Zhang WH, Lyu SC and Lang R contributed to conceiving the research, analyzing data and revised the manuscript; Lyu SC and Lang R provided administrative support; All authors read and approved the final manuscript.
Supported by the Beijing Natural Science Foundation, No. 7222303.
Institutional review board statement: This study was reviewed and approved by the Ethics Committee of Beijing Chao-Yang Hospital, No. 2024-D-511.
Informed consent statement: This study has been granted exemption from informed consent. All procedures and protocols were reviewed and approved by the Institutional Review Board (IRB) prior to the commencement of the study. The IRB determined that the study met the criteria for exemption under the federal regulations governing human subject’s research. We have followed all necessary ethical guidelines and regulations throughout the study.
Conflict-of-interest statement: All the Authors have no conflict of interest related to the manuscript.
Data sharing statement: All data and materials are available from the corresponding author.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ren Lang, MD, PhD, Director, Doctor, Professor, Department of Hepatobiliary Surgery, Beijing Chao-Yang Hospital Affiliated to Capital Medical University, No. 8 Gongti South Road, Chaoyang District, Beijing 100020, China. dr_langren@126.com
Received: July 3, 2024
Revised: August 5, 2024
Accepted: August 13, 2024
Published online: September 27, 2024
Processing time: 76 Days and 19.3 Hours
Core Tip

Core Tip: The objective of this research was to evaluate the prognostic relevance of the systemic inflammatory response index (SIRI) in patients diagnosed with distal cholangiocarcinoma (dCCA) post-pancreatoduodenectomy (PD). A retrospective collection of all clinicopathological data was undertaken to further investigate the utility of SIRI in prognostication for dCCA patients post-PD. The results indicated that SIRI could potentially serve as a prognostic indicator for both overall survival and recurrence-free survival in dCCA patients following PD. Elevated levels of SIRI could predict recurrence and long-term survival in dCCA patients, thereby providing valuable guidance for treatment strategies.